My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 217

    1.

    Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection.

    Baffis V, Shrier I, Sherker AH, Szilagyi A.

    Ann Intern Med. 1999 Nov 2;131(9):696-701. Review.PMID: 10577333 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    NIH consensus development statement on management of hepatitis B.

    [No authors listed]

    NIH Consens State Sci Statements. 2008 Oct 22-24;25(2):1-29.PMID: 18949020 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

    Mazzella G, Accogli E, Sottili S, Festi D, Orsini M, Salzetta A, Novelli V, Cipolla A, Fabbri C, Pezzoli A, Roda E.

    J Hepatol. 1996 Feb;24(2):141-7.PMID: 8907566 [PubMed - indexed for MEDLINE]Related articles

    4.

    Risk factors and prevention of hepatocellular carcinoma in HCV infection.

    Benvegnù L, Alberti A.

    Dig Dis Sci. 1996 Dec;41(12 Suppl):49S-55S.PMID: 9011476 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma]

    Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Takemura S, Shiomi S, Kinoshita H.

    Gan To Kagaku Ryoho. 2001 Dec;28(13):1975-9. Review. Japanese. PMID: 11791377 [PubMed - indexed for MEDLINE]Related articles

    6.

    Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach.

    Cammà C, Giunta M, Andreone P, Craxì A.

    J Hepatol. 2001 Apr;34(4):593-602.PMID: 11394661 [PubMed - indexed for MEDLINE]Related articles

    7.

    Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.

    Testino G, Ansaldi F, Andorno E, Ravetti GL, Ferro C, De Iaco F, Icardi G, Valente U.

    Hepatogastroenterology. 2002 Nov-Dec;49(48):1636-8.PMID: 12397752 [PubMed - indexed for MEDLINE]Related articles

    8.

    Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

    Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, Inoue O, Yano M, Tanaka M, Fujiyama S, Nishiguchi S, Kuroki T, Imazeki F, Yokosuka O, Kinoyama S, Yamada G, Omata M.

    Ann Intern Med. 1999 Aug 3;131(3):174-81.PMID: 10428733 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    NIH Consensus Statement on Management of Hepatitis C: 2002.

    [No authors listed]

    NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. Review.PMID: 14768714 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    HCV-hepatocellular carcinoma: new findings and hope for effective treatment.

    Dash S, Haque S, Joshi V, Prabhu R, Hazari S, Fermin C, Garry R.

    Microsc Res Tech. 2005 Nov;68(3-4):130-48. Review.PMID: 16276514 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha Hepatocellular Carcinoma Study Group.

    [No authors listed]

    Lancet. 1998 May 23;351(9115):1535-9. Erratum in: Lancet 1998 Oct 10;352(9135):1230. PMID: 10326535 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prevention of hepatocellular carcinoma in hepatitis B virus infection.

    Lim SG, Mohammed R, Yuen MF, Kao JH.

    J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. Review.PMID: 19702903 [PubMed - indexed for MEDLINE]Related articles

    13.

    Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.

    Bird SM, Goldberg DJ, Hutchinson SJ.

    J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.PMID: 11437088 [PubMed - indexed for MEDLINE]Related articles

    14.

    Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil.

    Alencar RS, Gomes MM, Sitnik R, Pinho JR, Malta FM, Mello IM, Mello ES, Bacchella T, Machado MC, Alves VA, Carrilho FJ.

    Braz J Med Biol Res. 2008 Mar;41(3):235-40. Epub 2007 Nov 29.PMID: 18097499 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.

    Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, Kudo M, Sato T, Chiba T.

    Ann Intern Med. 2007 May 1;146(9):649-56.PMID: 17470833 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.

    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.

    Scand J Gastroenterol. 2008;43(7):849-56.PMID: 18584524 [PubMed - indexed for MEDLINE]Related articles

    17.

    Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot study.

    Ikeda K, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, Tsubota A, Arase Y, Murashima N, Chayama K, Kumada H.

    J Gastroenterol Hepatol. 2001 Apr;16(4):406-15.PMID: 11354279 [PubMed - indexed for MEDLINE]Related articles

    18.

    What surgeons should know about viral hepatitis and hepatocellular carcinoma.

    Hassoun Z, Gores GJ.

    Surg Oncol Clin N Am. 2003 Jan;12(1):1-11, vii. Review.PMID: 12735125 [PubMed - indexed for MEDLINE]Related articles

    19.

    The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients.

    Silva C, Gonçales NS, Pereira JS, Escanhoela CA, Pavan MH, Gonçales FL Jr.

    Braz J Infect Dis. 2004 Dec;8(6):431-9. Epub 2005 May 9.PMID: 15880234 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.

    Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.

    J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. Epub 2007 Jun 7.PMID: 17559381 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity